Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Also, gods and demi gods are extremely in right now, Thor, Maui, the movie shape of water etc...
I was thinking of ways to improve our brand recognition, and presentation is a major key to that, I think using images of gods from an anciente culture for BEYOND HUMAN (beyond human, gods...get it?) would be easily recognizable and might call the attention of buyers, open the link for an example
https://www.google.com/search?biw=320&bih=267&tbm=isch&sa=1&ei=_5T7Wp-lEcuJ5wLyz7OoBA&q=ra&oq=&gs_l=mobile-gws-wiz-img.1.2.35i39l3.0.0..11191...2....0.0.......0....1.......3.%2ByFgHXpE54g%3D#imgrc=R5B8538l_jW7ZM:
besides, it wont offend anyone since its a dead theology and I don't think it infringes any trademark
big deal, everybody knows the MM rule: buy the rumor, sell the news, and today they sold, however for their game to continue they will have to buy and when they do the stock will go up up up. My first rule of the game: understand the game.
it's not a loss when the money has being invested to create brand recognition... it's an investment. Let me break it out for you:
3.5 million where invested in marketing and we lost 1.8 million, that means we had 1.7 million in profits but we decided to reinvest them and an additional 1.8m to get the word out about our product... Coca cola did the same when they were growing half a century ago and look at them now.
Guys, our record breaking quarter is being advertised in network news wire, expect new investors... geeeeeeeeehaaaaaaaaaaaaaaa!!!
Looks like someone is about to lose his shirt.. or should I say his rainbow fur??
THIS IS HUGE!!!THIS IS HUGE!!!THIS IS HUGE!!!
Musclin™. Musclin™ is a proprietary supplement made of two FDA Generally Recognized As Safe (GRAS) approved ingredients designed to increase muscle mass, endurance and activity. The main ingredient in Musclin™ is a patent-pending natural activator of the transient receptor potential cation channel, subfamily V, member 3 (TRPV3) channels on muscle fibers responsible to increase width of myotubules in fibers width resulting in larger muscles and higher endurance. We currently expect to launch this product in the second half of 2018.
THIS IS HUGE!!!THIS IS HUGE!!!THIS IS HUGE!!!
No one believes you anymore, you are a fantasy just like the rainbow unicorn cat of your profile pic, what is real are our sales, they are growing at an unbelievable rate and you can't stand that; I have a suggestion, go and cry with Cinderella and Pocahontas in Neverland.
True trades, the only thing true about you is the rainbow unicorn cat you have as a profile picture...oh wait!!
YES SR!!!!!
Relax, I'counting on all the xyralid you will buy once we reach profitability, that will send our revenues to the roof. Oh, by the way Batermere was absolutely right, Dr Da is in an under promise over deliver mode so be generous when using our product :)
one thousand posts and only followed by 3 people... no wonder why!!!
WOW, no chat activity for the last couple of week and now that we are up the bad boys show up. I see a lot of fear before Monday's great conference call, but please tell us what are you really afraid of the most, 4.3 to 4.4M in sales for the first quarter? April's possible unbelievable numbers? Possible profitability? I told every one to buy cheap shares when you had a chance, now no one is selling their shares cheap... get out of the way because it's blast off time!!!
Hey Batermere, that would be awesome however I believe we should stick with the lowest number...4.3 million, If we go higuer we will celebrate, if we don't then we won't be disappointed.
Beautiful week ahead of us. INNV to the moon.
Patience, our time is coming.
Smells like Fiji already.
Innovus Pharmaceuticals to Release Its First Quarter 2018 Financial Results on Monday, May 14, 2018
6:00 am ET May 4, 2018 (BusinessWire) Print
Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB: INNV), today announced that the Company will release its March 31, 2018 first quarter financial results on Monday, May 14, 2018, after the close of the U.S. financial markets. The Company will host a conference call at 4:15 p.m. ET/1:15 p.m. PT on the same day to discuss the financial results and recent business developments.
To participate in the call, please dial 1-877-883-0383 for domestic callers or 1-412-902-6506 for international callers or 1-877-885-0477 for Canadian callers and Participant Elite Entry Number: 9576665. A replay of the call will be available for 30 days. To access the replay, dial 1-877-344-7529 domestically or 1-412-317-0088 internationally or 1-855-669-9658 for Canada and reference Conference ID: 10118224. The replay will be available shortly after the end of the conference call.
About Innovus Pharmaceuticals, Inc.
Headquartered in San Diego, Innovus Pharma is an emerging OTC consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality and respiratory diseases. Innovus Pharma delivers innovative and uniquely presented and packaged health solutions through its (a) OTC medicines and consumer and health products, which we market directly, (b) commercial partners to primary care physicians, urologists, gynecologists and therapists, and (c) directly to consumers through our on-line channels, retailers and wholesalers. The Company is dedicated to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application ("ANDA") products. The Company is actively pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (or Rx) to OTC.
For more information, go to www.innovuspharma.com; www.zestra.com; www.ejectdelay.com; www.myvesele.com; www.urivarx.com; www.sensumplus.com; www.myandroferti.com; www.beyondhumantestosterone.com; www.getbeyondhuman.com; www.trybeyondhuman.com; www.recalmax.com; www.prostagorx.com; www.fluticare.com; www.allervarx.com; and www.apeaz.com.
Innovus Pharma's Forward-Looking Safe Harbor:
Statements under the Private Securities Litigation Reform Act, as amended: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risks and uncertainties that may individually or mutually impact the matters herein described for a variety of reasons that are outside the control of the Company, including, but not limited to, projected revenues from its various products, estimated market for its products, and statements about achieving its other development, growth, commercialization, financial and staffing objectives. Readers are cautioned not to place undue reliance on these forward-looking statements as actual results could differ materially from the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's most recent filing on Form S-1, annual report on Form 10-K, subsequent quarterly reports filed on Form 10-Q and other filings made with the SEC. Copies of these reports are available from the SEC's website or without charge from the Company.
I'm not Mrs Clio to know the future but what I can do is an educated guess based on facts.
Fact number one: we sold 4.3 million in the first quarter (based on last PR)
Fact number 2: fluticare began to be sold at amazon in December so we did't have many repeated customers in the first quarter just new ones.
Fact number 3: allergy season lasts most of the year and even the forth quarter gets some action, I leave you a link to reinforce this. https://www.weatherbug.com/news/When-Are-The-Worst-Times-For-Allergies
Fact number 4: our best seller last year was Urivarx and we were able to sell 8.8 million dollars worth of products mostly without Amazon, Ebay, Walmart and wish sales; with Fluticare that number should grow exponentially.
Based on facts this is my verdict: You are right about last quarter, it might be the weakest of all 4 but I think we are going to see strong numbers in quarter 2 and 3 to gets us to 18 million dollars and hopefully higher.
Zestra, Sensum, Fluticare, Urivarx and arthrivarx continue to collect reviews at Amazon, and you know what that means... sales, lots of them.
Not every company runs the same fate, everything will come down to the real value of the company, if you really see a future, if you see potential and an uptrend in sales then we will not only stay in Nasdaq but big institutions and large investors will want a piece of the pie and that's when a company worth 50 million goes to be billions of dollars. Let me give you an example, let's say Xyralid becomes the number two seller for hemorrhoid treatment in the world after preparation H and is growing at a faster pace than preparation H, do you think the S/P will go up or down? would you sell your shares? or would you if Fluticare is selling extremely well but the following month will appear on national TV which will boost its sells even more? all I'm saying is this, as long as we have ways to increase revenues year after year the stock is not going to die, whether in Nasdaq or OTC. At this point the future looks fantastic and I don't care if we go to Nasdaq or not, I want us to sell 18 million plus this year and have ways to sell more in 2019.
GI, I agree with you in a lot of your points however I truly believe we are moving forward, they made mistakes in the past and they are correcting them as we go. INNV is not the same company it was a year ago, stronger foundation is being built as we speak and as sales grow so will the stock price, be patient. After DR Damaj projected 18 millions in sales for the year I realized he learned from his previous mistakes, I think he low balled it on purpose and believe me no one is going to be disappointed this year. Advertising our product in the news paper is a big step up and so is to be selling at Amazon and the rest of the platforms, now we know for sure they are selling and the best part is we are making huge margins, what else can you ask for to an OTC company. I'm the happiest guy in the world and my average stock price is 0.165. The future looks absolutely brilliant and that is my lighthouse, I'll just keep sailing my friend!!!
FIJI IS NEAR!!!!
May is here and May smells like flowers, like wine, like money...oh yeah, may smells good. INNV TO THE MOON.
We are one day away from the month that will change everything; fist quarter results will be released in the middle of the month and 1st month of the second quarter results might be released consolidating our uptrend in sales and revenues. Let me be the first one to welcome you to MONEYLAND!!!
_________________________________________________________________
This is my opinion and I might be wrong but in my mind I have no doubts!!
Innovus Pharma Announces the Launch of its Hemorrhoid Drug Xyralid(R) in Canada
6:00 am ET April 26, 2018 (BusinessWire) Print
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, today announced the launch of its lidocaine-based cream Xyralid(R), for the relief of pain and symptoms caused by hemorrhoids. Xyralid(R) received a Product License Application ("PLA") in Canada and the product is available as an over-the-counter ("OTC") or behind the counter drug and will not require a prescription. The product is available in Canada directly through the Company's website and through its Beyond Human(R) marketing and sales platform.
"We are very happy to announce the launch of Xyralid(R) in Canada," said Dr. Bassam Damaj, the President and Chief Executive Officer of Innovus Pharma. "Xyralid(R) represents the second product launched through our own sales and marketing commercial efforts in Canada in addition to Apeaz(R) and is our sixth product on the Canadian market including Zestra(R), Zestra Glide(R) and Uxor(TM) (EjectDelay(TM)) marketed by Orimed Pharma and UriVarx(R) through our partnership with Acerus Pharmaceuticals Corporation."
About Xyralid(R)
Xyralid(R) is an FDA and Health Canada-OTC monograph compliant, fast-acting and powerful hemorrhoid anesthetic cream. It contains the active ingredient drug, lidocaine, which provides fast relief for the pain and symptoms caused by hemorrhoids.
Hemorrhoids, also called "piles", are swollen and inflamed veins in the anus and lower rectum. Hemorrhoids may result from straining during bowel movements or from the increased pressure on these veins during pregnancy, among other causes. Hemorrhoids may be located inside the rectum (internal hemorrhoids) or they may develop under the skin around the anus (external hemorrhoids). There are over 1.2 million hemorrhoid sufferers in Canada making it a very large market(1).
About Innovus Pharmaceuticals, Inc.
Headquartered in San Diego, Innovus Pharma is an emerging OTC consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality and respiratory diseases. Innovus Pharma delivers innovative and uniquely presented and packaged health solutions through its (a) OTC medicines and consumer and health products, which we market directly, (b) commercial partners to primary care physicians, urologists, gynecologists and therapists, and (c) directly to consumers through our on-line channels, retailers and wholesalers. The Company is dedicated to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application ("ANDA") products. The Company is actively pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (or Rx) to OTC.
For more information, go to www.innovuspharma.com; www.zestra.com; www.ejectdelay.com; www.myvesele.com; www.urivarx.com; www.sensumplus.com; www.myandroferti.com; www.beyondhumantestosterone.com; www.getbeyondhuman.com; www.trybeyondhuman.com; www.recalmax.com; www.prostagorx.com; www.fluticare.com; www.allervarx.com; and www.apeaz.com.
Innovus Pharma's Forward-Looking Safe Harbor:
Statements under the Private Securities Litigation Reform Act, as amended: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risks and uncertainties that may individually or mutually impact the matters herein described for a variety of reasons that are outside the control of the Company, including, but not limited to,
Someone is trying to buy cheap shares, it won't be mine, that's for sure!!!
Guys please relax, investing in INNV is like a walk in the park, you are going to sweat a little but the front view is excellent. When you know your company doubled it's sales in 2017 compared to 2016 and you know in the first quarter of the year you did half of what you did the whole previous year you know great things are about to happen. Now, speaking of people who knows something let me tell you this, I know something... we are the number 79 seller in amazon in the allergy department and that is just fluticare sales, but remember this, last year Fluti wasn't our best seller, Urivarx was and it seems like Zestra is killing it in amazon, not to mention all the other pages like walmart, wish and ebay.
Conclusion, relax, enjoy the walk, enjoy the view and last but not least enjoy the profits... they are coming.
This is my opinion and you should do your own DD but in my mind I have no doubt!!!
Hey Shawn, please continue to push the stock down, I want to add another 2 million shares before it pops up... Thank you!!! along with True trades you are the most productive employee I have and I don't even have to pay you. I might even buy you tickets to Fiji... mmmm, may be not!!!
Very easy, let's say you get a job offer including Venezuelan or Somalian treasury bonds redeemable in the future, wouldn't you try to get cash instead knowing those are basically garbage? Well, it seems that our VP sees potential or at least stability in our stock and that my friend inspires confidence!!!!
Fiji is getting closer!!!
BOOOOOOOOOOOOOOOOOOOM BABY!!!
Fiji is getting closer!!!
Best thing is this, while they waste their time trying to hijack this stock, our cash registers are going Ka-shing, ka- shing 24/7. The internet (amazon, walmart.com, wish and e bay) doesn't sleep.
Fiji awaits us!!!
The market is not responding? go ahead take a look again, look closer and take your basher goggles off, since we Fluti started selling in amazon we went from 8 cents to a new low of 0.113, then our new low was 0.12 and it was tested twice and now we are at 0.136. Go ahead and try to lie to us, but you will never be able to lie to yourself.
based on my DD I really think we will do great, I encorage you and everyone in this panel to do your own DD but as far as I can see this stock won't remain at this level much longer, the three guys who are trying to hijack the stock won't be able to resist a real rush and then they will have to cover their positions which will work as a slingshot sending INNV to the moon.
The only thing we need is more exposure and I urge management to work on this matter, here is a page that could help us with that:
https://www.networknewswire.com
Fiji awaits us!!!
Fist thing I ask before investing, are they stable? INNV has being established for many years.
What is the game changer? INNV has being commercializing it's products organically but now they are selling in the biggest market in the world, furthermore they are adding new products to their line and as a result it's virtually impossible for the numbers to remain the same or retrace.
Can they continue to grow? of course, INNV just introduced one of their products in the Canadian market, they can do the same with the rest of their line of products and also they can replicate this in every other country in the world and INNV is working on new products that will utilize every commercialization channel we have opened in the past, the sky is the limit.
Are the goals reachable? absolutely, 4.3 million in sales the first quarter is half of what we sold in ALL of 2017 and it's not even allergy season yet, besides some of our new products haven't reach the market yet... I'm not going to speculate with a number, instead I'm going to stick with DR Da's projection of 18 million for the year which would be more than double the amount we sold last year.
FIJI AWAITS US!!!
Yes Sr!!!
I want to share with you a true story, and you can go back in to my old post to confirm it, about 10 months ago I started telling everyone about POTN, a company with great potential in the CBD market, I bought 3.2 million shares of it and told everyone to load up before the beginning of 2018, my PPS was 6 cents, the stock started to grow like crazy dec 28 2017 and almost touched a dollar per share, I sold all my shares at an average of 0.42 cents making a huge amount of money just based on fundamentals; True trades reminds me of a lot of the bashers I had to confront at the time, they were very proud while the stock wasn't moving but that was the perfect time for me to load up since I knew the potential. Today I own almost 5.2 million shares of INNV (if you don't believe me please look in level 2 the position sitting at 1.92 dollars per share, yeah, that's me). I will not sale any of my stocks in the near future, I have very high expectations about this company.
At that time I kept saying once we hit it big we will go to Fiji, I already hit it big and instead I end up going to Galapagos Islands (far more interesting than Fiji) however, I will end up going to Fiji when we make it with INNV since I already check marked Galapagos.
Oh, by the way, if you go there try to stay at villa escalesia in Puerto Ayora, look it up in google, it's the same house were Brad Pitt and Angelina stayed at when the were there, ask Ivan, the butler about Victor Alcocer, I know he remembers me!!! cheers my friends!!!
True, but as you said that's for people who are already signed up with INNOVUS and they are already investors, what we need is for this information to get to new potential investors. The other way to advertise our company is by going to every trade show related to pharma, the more people knows us the more investors we will have.
Let's get Innovus going!!!
Good morning DrugDoctor, I see that you are a moderator and a very active member of this chat, I'm assuming you have direct communication with Innovus, if that's the case tell them we need more exposure, we have too many good news to share but we need an audience and the way to do it is by having press releases going straight to people's emails, going to national radio and sharing the new developments of our company, we can use "Mick Bazsuly Show" to do that. I have no doubt in my mind this company will grow whether we do it or not but we might grow extremely fast if we do!!!
INNV to the moon.
competition is part of the business, and let me share a great example why we are going to do great with competition, do you guys know which bottle of wine is the best seller at any restaurant? the second least expensive, why? because almost everyone thinks they deserve better than the cheap stuff, but most can't afford to pay higher prices. We are priced right and we are making great margins. Time for a bottle of wine, cheers!!!
Costco's fluticasone is considered a generic product, while fluticare is a branded product.
Nothing will stop innovus from succeding, we have very exciting times ahead of us.